Yusef Badi
About Yusef Badi
Yusef Badi is a Precision Medicine Data Scientist at BenevolentAI in London, with extensive experience in bioinformatics and computational biology.
Precision Medicine Data Scientist at BenevolentAI
Yusef Badi is currently employed as a Precision Medicine Data Scientist at BenevolentAI in London, England, United Kingdom. His role involves leveraging his expertise in data science to drive advancements in precision medicine. He contributes to the analysis and interpretation of complex datasets, aiming to develop personalized medical solutions.
Previous Experience at GSK
Yusef Badi completed a one-year industrial placement at GSK in Stevenage, England, United Kingdom, from 2020 to 2021. During his tenure, Badi was involved in various research projects and industry activities that furthered his knowledge and experience in the pharmaceutical field.
Educational Background
Yusef Badi holds multiple degrees in sciences and data analytics. He completed a Doctor of Philosophy (PhD) in Pharmaco-omics Data Science at Imperial College London from 2017 to 2022. Prior to that, he obtained a Master's degree in Bioinformatics and Computational Biology from Queen Mary University of London in 2017, and a Master's degree in Oncology and Radiation Biology from the University of Oxford in 2015. He also holds a Bachelor's degree in Biological Sciences and Biochemistry from Queen Mary University of London, achieved in 2014.
Research Experience
Yusef Badi has amassed extensive research experience through various positions. He served as an MSc Research Scientist at Barts Cancer Institute and the University of Oxford. He has held research scientist roles during summer internships at UCL and Imperial College London. His research experience spans analytical tools development, transcriptomic and genetics analyses, and conducting studies at prestigious institutions including the Institute for Liver and Digestive Health and the Magdi Yacoub Institute.
Industry Collaborations and Leadership
Throughout his career, Yusef Badi has led precision medicine work for internal disease and target projects, as well as a collaboration with AstraZeneca focused on Systemic Lupus Erythematosus. His leadership in these projects has been pivotal in developing and implementing analytical tools and conducting robust transcriptomic and genetics analyses, including GWAS and PheWAS.